EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin

Kana Tanahashi, Michihiro Kono, Takenori Yoshikawa, Yuika Suzuki iD, Masukazu Inoie, Yachiyo Kuwatsuka, Fumie Kinoshita, Takuya Takeichi iD, Masashi Akiyama iD

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Kana Tanahashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Hyperkeratosis, Epidermolytic, Keratinocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: was, AMED, Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

No efficient treatment has yet been established for epidermolytic ichthyosis (EI), which is caused by pathogenic variants of KRT1 or KRT10. Patients with ichthyosis with confetti (IWC) have multiple normal-appearing spots, caused by the revertant somatic recombination of pathogenic variants that occurs at each spot independently. Additionally, some patients with EI have large areas of normal skin due to revertant postzygotic mosaicism.

Objectives

To assess the feasibility of transplanting cultured epidermal autografts (CEAs) produced from revertant epidermal keratinocytes in patients with EI and IWC.

Methods

We performed a clinical trial of treatment with CEAs produced from each patient’s own revertant epidermal keratinocytes as a proof-of-concept study. This was a single-arm, open, unmasked, uncontrolled, single-assignment, treatment-purpose study. The primary outcome was the percentage area that lacked recurrence of ichthyosis lesions 4 weeks after the final transplant. The secondary outcome was the percentage area lacking recurrence of ichthyosis lesions 24 weeks after the initial transplantation. The trial was registered with the Japan Registry of Clinical Trials (jRCTb041190097).

Results

We successfully produced CEAs from genetically confirmed revertant skin from two patients with mosaic EI and from one patient with IWC and confirmed by amplicon sequencing and droplet digital polymerase chain reaction analysis that the CEAs mainly consisted of revertant wild-type cells. Single-cell RNA sequencing analysis confirmed the normal proliferation and safety profiling of CEAs. CEAs were transplanted onto desquamated lesional sites in the patients. Four weeks post-transplantation, the percentage area lacking recurrence of ichthyosis lesions in the three patients was 40%, 100% and 100% respectively, although recurrence of ichthyosis lesions was seen at the site of CEA transplantation in all three patients at 24 weeks post-transplantation.

Conclusions

CEAs from normal skin have the potential to be a safe and local treatment option for EI and IWC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperkeratosis, EpidermolyticKeratinocytesHumansMaleFemaleChildAdultSkin TransplantationAutograftsEpidermisKeratin-10AdolescentFeasibility StudiesKeratin-1Young AdultProof of Concept StudyTransplantation, AutologousTreatment OutcomeChild, PreschoolMosaicismIchthyosis

Substanzen

Keratin-10KRT10 protein, humanKeratin-1KRT1 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Japan Tissue Engineering Co., Ltd., Gamagori, Japan.
  • Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Nagoya University Institute for Advanced Research, Nagoya, Japan.

ORCID-Profile: Yuika Suzuki, Takuya Takeichi, Masashi Akiyama

Förderung

  • was
  • AMED
  • Health
  • the
  • Ministry of Health
  • JSPS
  • JST

Zitieren

APA

Tanahashi, K., Kono, M., Yoshikawa, T., Suzuki, Y., Inoie, M., Kuwatsuka, Y., Kinoshita, F., Takeichi, T., & Akiyama, M. (2024). Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae193

Vancouver

Tanahashi K, Kono M, Yoshikawa T, Suzuki Y, Inoie M, Kuwatsuka Y, et al. Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae193

BibTeX
@article{Tanahashi2024,
  author = {Tanahashi, Kana and Kono, Michihiro and Yoshikawa, Takenori and Suzuki, Yuika and Inoie, Masukazu and Kuwatsuka, Yachiyo and Kinoshita, Fumie and Takeichi, Takuya and Akiyama, Masashi},
  title = {Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae193}
}
Kostenlos starten →